INTRADERMAL AND INTRAMUSCULAR ROUTE FOR VACCINATION AGAINST HEPATITIS-B

被引:30
作者
GONZALEZ, ML [1 ]
USANDIZAGA, M [1 ]
ALOMAR, P [1 ]
SALVA, F [1 ]
MARTIN, F [1 ]
ERROZ, MJ [1 ]
LARDINOIS, R [1 ]
机构
[1] ITEM PHARMA,MADRID,SPAIN
关键词
Hepatitis B; intradermal; intramuscular; recombinant vaccine;
D O I
10.1016/0264-410X(90)90102-R
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A recombinant hepatitis B vaccine was administered to high-risk hospital personnel by intramuscular (20 μg) or intradermal (2 μg) injections for the primary immunization (n = 69) with three doses and booster immunization (n = 51) with one dose. Basic vaccination performed intramuscularly gave rise to significantly higher seroconversion levels (97.2% versus 78.1%) and geometric mean titres of antibody (1649 versus 126 IUI-1) as compared with the intradermal route. Intradermal administration did not boost antibody titres in patients previously vaccinated intradermally. Adverse reactions were not serious or severe. The intramuscular route is recommended as the procedure of choice when vaccinating against hepatitis B. © 1990.
引用
收藏
页码:402 / 405
页数:4
相关论文
共 17 条
  • [1] DIENSTAG JL, 1986, JAMA-J AM MED ASSOC, V256, P351
  • [2] THE MATERNAL-INFANT CENTER IN THE CONTROL OF HEPATITIS-B
    GONZALEZ, L
    ROSES, A
    ALOMAR, P
    DELVALLE, JM
    GARAU, A
    FERRER, P
    MAIMO, M
    LLINARES, R
    BLANCO, I
    LARDINOIS, R
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1988, 67 (05) : 421 - 427
  • [3] GONZALEZ ML, 1988, CLIN INVEST GIN OBST, V15, P32
  • [4] INTRADERMAL HEPATITIS-B VACCINATION IN AN ABBREVIATED SCHEDULE
    HALSEY, NA
    REPPERT, EJ
    MARGOLIS, HS
    FRANCIS, DP
    FIELDS, HA
    [J]. VACCINE, 1986, 4 (04) : 228 - 232
  • [5] DURATION OF IMMUNITY AFTER HEPATITIS-B VACCINATION - EFFICACY OF LOW-DOSE BOOSTER VACCINE
    HOROWITZ, MM
    ERSHLER, WB
    MCKINNEY, WP
    BATTIOLA, RJ
    [J]. ANNALS OF INTERNAL MEDICINE, 1988, 108 (02) : 185 - 189
  • [6] IRVING WL, 1987, LANCET, V2, P561
  • [7] IRVING WL, 1986, LANCET, V2, P1340
  • [8] JILG W, 1984, LANCET, V2, P1174
  • [9] KRUGMAN S, 1987, YALE J BIOL MED, V60, P333
  • [10] INTRADERMAL HEPATITIS-B VIRUS-VACCINE - IMMUNOGENICITY AND SIDE-EFFECTS IN ADULTS
    MILLER, KD
    GIBBS, RD
    MULLIGAN, MM
    NUTMAN, TB
    FRANCIS, DP
    [J]. LANCET, 1983, 2 (8365) : 1454 - 1456